ISTR vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 07, 2026

ISTR

56.5
AI Score
VS
CARE Wins

CARE

67.4
AI Score

Investment Advisor Scores

ISTR

57score
Recommendation
HOLD

CARE

67score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ISTR CARE Winner
Forward P/E 9.8425 13.6612 ISTR
PEG Ratio 0 0 Tie
Revenue Growth 66.2% 68.3% CARE
Earnings Growth 33.5% 253.9% CARE
Tradestie Score 56.5/100 67.4/100 CARE
Profit Margin 27.7% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY CARE

Relative Price Performance (Last 90 Days)

ISTR 1M: +3.3% · 3M: +7.1% CARE 1M: -5.7% · 3M: +12.1%

Current Technical Phase

ISTR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 62

RSI (14): 61.9 · Price: $31.10

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $31.98

Fundamentals Snapshot

Metric ISTR CARE
Market Cap
Forward P/E 9.4 12.3
Trailing P/E 12.7 5.5
Revenue (TTM)
Revenue Growth 0.7% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 2.42 5.80
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.